901 studies found for:    glioblastoma
Show Display Options
Rank Status Study
21 Unknown  A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
Condition: Glioblastoma
Intervention: Procedure: FDG-PET
22 Unknown  Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
Condition: Glioblastoma
Intervention: Drug: Temozolomide
23 Completed PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
Condition: Glioblastoma
Interventions: Drug: PTK787/ZK 222584;   Drug: Temozolomide;   Procedure: Radiation Therapy
24 Not yet recruiting Spatial Analysis and Validation of Glioblastoma on 7 T MRI
Condition: Glioblastoma
Interventions: Device: 7 T MRI;   Procedure: Biopsy
25 Completed A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: MEDI-575
26 Recruiting Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Radiation: Radiochemotherapy
27 Terminated A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme;   Glioma;   Astrocytoma;   Brain Tumor
Intervention: Drug: Intrathecal liposomal Ara-C + Temozolomide
28 Recruiting WEE1 Inhibitor MK-1775, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: WEE1 inhibitor MK-1775;   Radiation: radiation therapy;   Drug: temozolomide;   Other: pharmacological study;   Other: laboratory biomarker analysis
29 Terminated Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: TLN-4601
30 Recruiting Efficacy, Safety and CNS Exposure of G-202 in Patients With Recurrent or Progressive Glioblastoma
Conditions: Recurrent Glioblastoma;   Progressive Glioblastoma
Intervention: Drug: G-202
31 Recruiting BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)
Conditions: GBM;   Glioblastoma Multiforme;   Gliosarcoma
Intervention: Drug: PSMA ADC
32 Recruiting A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma
Condition: Glioblastoma
Interventions: Other: Chemoradiation Therapy;   Other: Adjuvant Therapy
33 Recruiting PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Conditions: Glioblastoma;   Cancer of Brain and Nervous System;   Glioblastoma Multiforme
Interventions: Drug: Temozolomide;   Procedure: Stereotactic Radiosurgery
34 Active, not recruiting Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Condition: Glioblastoma
Interventions: Drug: cediranib maleate;   Drug: gefitinib;   Drug: Placebo
35 Active, not recruiting A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Condition: Recurrent Glioblastoma
Intervention: Drug: PLX3397
36 Withdrawn Bevacizumab With or Without Surgery for Adult Glioblastomas
Conditions: Glioblastoma;   Brain Neoplasm
Intervention: Procedure: Craniotomy
37 Unknown  Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
Condition: Glioblastoma
Intervention: Radiation: Magnetic Resonance Imaging (MRI)
38 Active, not recruiting Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
Conditions: Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma
Interventions: Drug: XL184;   Drug: temozolomide;   Radiation: Radiation Therapy
39 Active, not recruiting Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: XL184
40 Terminated Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
Conditions: Glioblastoma;   CNS Disease;   Brain Diseases
Interventions: Drug: Dasatinib;   Radiation: RT (Radiotherapy);   Drug: TMZ (Temozolomide)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years